Long-term real-world evidence for sustained clinical benefits of fingolimod following switch from natalizumab

MS Treatments

Jahr

Publikationsjahr
2020

Autoren

Autorenliste der Publikation
Ziemssen T, Lang M, Tackenberg B, Schmidt S, Albrecht H, Klotz L, Haas J, Lassek C, Cornelissen C, Ettle B; PANGAEA Study Group.

Verlag

Publisher-Information
Mult Scler Relat Disord. 2020 Apr;39:101893.

Link

Zur Publikation (externer Server)
https://doi.org/10.1016/j.msard.2019.101893

Tags

Forschungsthemen
Multiple SkleroseMS Behandlung
Treatments2020